Published in Am J Hum Genet on April 01, 1989
Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest (1991) 1.56
Haemophilia B: database of point mutations and short additions and deletions--fourth edition, 1993. Nucleic Acids Res (1993) 1.49
Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Res (1996) 1.44
Haemophilia B: database of point mutations and short additions and deletions--third edition, 1992. Nucleic Acids Res (1992) 1.36
Haemophilia B: database of point mutations and short additions and deletions--second edition. Nucleic Acids Res (1991) 1.29
Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994. Nucleic Acids Res (1994) 1.21
Haemophilia B: database of point mutations and short additions and deletions. Nucleic Acids Res (1990) 1.20
Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins. J Clin Invest (1989) 0.91
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry (1985) 11.80
Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell (1984) 8.14
Detection and sequence of mutations in the factor VIII gene of haemophiliacs. Nature (1985) 2.30
Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet (1988) 1.93
Molecular genetics of human serum albumin: restriction enzyme fragment length polymorphisms and analbuminemia. Proc Natl Acad Sci U S A (1983) 1.89
Structure, function, and molecular defects of factor IX. Blood (1986) 1.37
An intragenic deletion of the factor IX gene in a family with hemophilia B. J Clin Invest (1985) 1.32
The molecular pathology of haemophilia B. Fourth Wellcome Trust lecture. Biochem Soc Trans (1987) 0.96
Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes. J Clin Invest (1987) 0.89
Delineation of prognostic biomarkers in prostate cancer. Nature (2001) 12.25
Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry (1985) 11.80
Linkage group I: the simultaneous estimation of recombination and interference. Birth Defects Orig Artic Ser (1976) 8.63
Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI. Proc Natl Acad Sci U S A (1987) 4.03
Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry (1984) 3.75
Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet (1998) 3.27
Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci U S A (1982) 3.14
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med (1998) 2.80
mtDNA and Y-chromosome polymorphisms in four Native American populations from southern Mexico. Am J Hum Genet (1994) 2.68
The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med (2000) 2.63
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum Mol Genet (1992) 2.32
Detection of the carrier state in combined immunodeficiency disease associated with adenosine deaminase deficiency. J Clin Invest (1974) 2.23
The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol (1979) 2.21
Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry (1985) 1.94
Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A (1981) 1.91
Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci U S A (1986) 1.89
A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry (1988) 1.89
Heritable fragile site on chromosome 16: probable localization of haptoglobin locus in man. Science (1970) 1.87
Activation of human factor IX (Christmas factor). J Clin Invest (1978) 1.82
Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc Natl Acad Sci U S A (1985) 1.75
Molecular cloning of a full-length cDNA for human alcohol dehydrogenase. Proc Natl Acad Sci U S A (1985) 1.74
Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes. Nature (1982) 1.70
Isolation, crystallization, and primary amino acid sequence of human platelet factor 4. J Biol Chem (1977) 1.68
Reliability and validity of breast cancer screening belief scales in African American women. Nurs Res (1998) 1.64
Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry (1986) 1.62
Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. Biochemistry (1984) 1.62
Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res (2000) 1.54
Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab (1982) 1.47
Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency. J Pediatr (1974) 1.46
Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis (2007) 1.44
Estimating distances from the centromere by means of benign ovarian teratomas in man. Ann Hum Genet (1976) 1.40
Characterization of unusual hexosaminidase A (HEX A) deficient human mutants. Am J Hum Genet (1978) 1.40
Human amylase loci: genetic linkage with the Duffy blood group locus and assignment to linkage group I. Am J Hum Genet (1973) 1.38
Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci U S A (1984) 1.36
Tandem duplication of proximal 22q: a cause of cat-eye syndrome. Am J Med Genet (1985) 1.33
A new craniodigital syndrome with mental retardation. J Pediatr (1971) 1.32
An intragenic deletion of the factor IX gene in a family with hemophilia B. J Clin Invest (1985) 1.32
Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc Natl Acad Sci U S A (1992) 1.30
Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry (1986) 1.29
Regional localization of the human factor IX gene by molecular hybridization. Hum Genet (1983) 1.28
Characterization of human, bovine, and horse antithrombin III. Biochemistry (1976) 1.28
Heterogeneity for adenosine deaminase deficiency: Expression of the enzyme in cultured skin fibroblasts and amniotic fluid cells. Am J Hum Genet (1975) 1.23
Syndrome of accelerated skeletal maturation and relative failure to thrive: a newly recognized clinical growth disorder. J Pediatr (1971) 1.23
The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J (1981) 1.23
Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor). Biochemistry (1977) 1.21
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20
The factor IX BamHI polymorphism: T-to-G transversion at the nucleotide sequence -561. The BamHI/MSPI haplotypes in blacks and Caucasians. Hum Genet (1989) 1.20
The neuropathology of the nonketotic and ketotic hyperglycinemias: three cases. Neurology (1978) 1.19
Nonrandomness of translocations in man: preferential entry of chromosomes into 13-15-21 translocations. Science (1968) 1.17
The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest (2000) 1.17
Human liver fibronectin complementary DNAs: identification of two different messenger RNAs possibly encoding the alpha and beta subunits of plasma fibronectin. Biochemistry (1986) 1.16
Adenosine-deaminase deficiency and severe combined immunodeficiency syndrome. Lancet (1973) 1.16
Inhibition of bovine factor IXa and factor Xabeta by antithrombin III. Biochemistry (1976) 1.16
Role of intron I in expression of the human factor IX gene. J Biol Chem (1995) 1.15
Structures of triclinic mono- and di-N-acetylglucosamine: lysozyme complexes--a crystallographic study. J Mol Biol (1976) 1.15
Purine nucleoside phosphorylase deficiency. Evidence for molecular heterogeneity in two families with enzyme-deficient members. J Clin Invest (1977) 1.13
Probable genetic linkage between human serum amylase (Amy 2 ) and Duffy blood group. Nature (1972) 1.13
Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery (2001) 1.12
Activation of bovine factor XII (Hageman factor) by plasma kallikrein. Biochemistry (1980) 1.12
Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem (1991) 1.10
Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates. Biochemistry (1981) 1.10
Formation and dissociation of the covalent complexes between trypsin and two homologous inhibitors, alpha 1-antitrypsin and antithrombin III. Eur J Biochem (1980) 1.10
Laboratory studies of a family manifesting premature exfoliation of deciduous teeth. J Clin Periodontol (1986) 1.10
Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc Natl Acad Sci U S A (1991) 1.09
Letter: cysteamine treatment in paracetamol overdose. Lancet (1975) 1.08
Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. J Biol Chem (1987) 1.08
Direct profiling of multiple enzyme activities in human cell lysates by affinity chromatography/electrospray ionization mass spectrometry: application to clinical enzymology. Anal Chem (2001) 1.07
Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood (1993) 1.06
MR imaging of phenylketonuria. AJNR Am J Neuroradiol (1991) 1.06
Induction of alpha 1-antitrypsin mRNA and cloning of its cDNA. Biochem Biophys Res Commun (1981) 1.05
Characterization of bovine factor XIIa (activated Hageman factor). Biochemistry (1977) 1.05
Expression of active human factor IX in transfected cells. Nature (1985) 1.05
The diagnostic significance of LH-releasing hormone test in patients with amenorrhea. Am J Obstet Gynecol (1974) 1.05
Recombination between two 14-bp homologous sequences as the mechanism for gene deletion in factor IX Seattle 1. Am J Hum Genet (1990) 1.04
Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet (1994) 1.02
Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice. Blood (1998) 1.02
Congenital malformations of newborn infants after clomiphene-induced ovulation. Fertil Steril (1983) 1.02
Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function. J Immunol (1979) 1.02
Human genes for complement components C1r and C1s in a close tail-to-tail arrangement. Proc Natl Acad Sci U S A (1988) 1.01
Augmentation of puerperal lactation by oral administration of sulpiride. J Clin Endocrinol Metab (1979) 1.01
Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol Genet Metab (2000) 1.00
Metal ion binding in triclinic lysozyme. J Biol Chem (1975) 1.00
Functional characterization of the 5'-regulatory region of human factor IX gene. J Biol Chem (1990) 1.00
Non-insulin dependent diabetes mellitus in African-American youths of Arkansas. Clin Pediatr (Phila) (1998) 1.00
Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation. J Clin Invest (1978) 0.99
Kinetics of recombinant adeno-associated virus-mediated gene transfer. J Virol (2000) 0.98
Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates. Biochemistry (1984) 0.97
Hereditary leukokeratosis, white mouth. J Pediatr (1966) 0.97
Advanced endocrine cell carcinoma of the gallbladder: a patient with 12-year survival. Hepatogastroenterology (1999) 0.97
Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Ther (1994) 0.97
Human chromosome variation: the discriminatory power of Q-band heteromorphism (variant) analysis in distinguishing between individuals, with specific application to cases of questionable paternity. Am J Hum Genet (1986) 0.96
Hereditary transcobalamin II deficiency: the role of transcobalamin II in vitamin B 12 -mediated reactions. J Pediatr (1972) 0.96
Human benign ovarian teratomas: chromosomal and electrophoretic enzyme studies. Birth Defects Orig Artic Ser (1978) 0.95
Mosaicism with translocation: autoradiographic and fluorescent studies of an inherited reciprocal translocation t(2q+;14q-). J Med Genet (1972) 0.95
Ovarian teratomas: cytologic data. Cytogenet Cell Genet (1976) 0.94